FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2380744585> ?p ?o ?g. }

• W2380744585 endingPage "269" @default.
• W2380744585 startingPage "261" @default.
• W2380744585 abstract "Background Irritable bowel syndrome is a multifactorial disease. Although faecal calprotectin has been shown to be a reliable marker of intestinal inflammation, its role in irritable bowel syndrome remains debated. Objective The aims of this prospective study were to select a subgroup of irritable bowel syndrome patients and to characterise those patients with high faecal calprotectin by systematic work-up. Methods Calprotectin levels were determined by enzyme-linked immunosorbent assay test in consecutive irritable bowel syndrome patients fulfilling Rome III criteria in whom normal colonoscopy and appropriate tests had excluded organic disease. Calprotectin levels were compared in irritable bowel syndrome patients, healthy controls and patients with active and quiescent Crohn’s disease. When the calprotectin level was higher than 50 µg/g, the absence of ANCA/ASCA antibodies and a normal small bowel examination were required to confirm irritable bowel syndrome diagnosis. Additional explorations included assessment of irritable bowel syndrome severity, anxiety and depression, impact on quality of life, glucose and fructose breath tests, rectal distension test by barostat and quantitative and qualitative assessment of inflammation on colonic biopsies. Results Among the 93 irritable bowel syndrome patients (73% women; 66.7% with diarrhoea) recruited, 34 (36.6%) had reproducibly elevated calprotectin. Although they tended to be older than those with normal calprotectin (P = 0.06), there were no other differences between the two groups. When elevated, calprotectin was correlated with age (P = 0.03, r = 0.22). Conclusions Elevated faecal calprotectin was observed in one third of patients in this series, without any significant association with a specific clinical phenotype (except age) or specific abnormalities." @default.
• W2380744585 created "2016-06-24" @default.
• W2380744585 creator A5017285164 @default.
• W2380744585 creator A5026870084 @default.
• W2380744585 creator A5027135372 @default.
• W2380744585 creator A5028721261 @default.
• W2380744585 creator A5034906246 @default.
• W2380744585 creator A5045593958 @default.
• W2380744585 creator A5064699932 @default.
• W2380744585 creator A5072898235 @default.
• W2380744585 creator A5073099637 @default.
• W2380744585 creator A5075930663 @default.
• W2380744585 date "2017-03-01" @default.
• W2380744585 modified "2023-10-16" @default.
• W2380744585 title "Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study" @default.
• W2380744585 cites W1523737655 @default.
• W2380744585 cites W1975629630 @default.
• W2380744585 cites W1976068711 @default.
• W2380744585 cites W1976947921 @default.
• W2380744585 cites W1979972888 @default.
• W2380744585 cites W1985076770 @default.
• W2380744585 cites W2002025728 @default.
• W2380744585 cites W2026661267 @default.
• W2380744585 cites W2028889492 @default.
• W2380744585 cites W2044044822 @default.
• W2380744585 cites W2046497206 @default.
• W2380744585 cites W2064201279 @default.
• W2380744585 cites W2064441871 @default.
• W2380744585 cites W2072498988 @default.
• W2380744585 cites W2077129981 @default.
• W2380744585 cites W2084589442 @default.
• W2380744585 cites W2085286494 @default.
• W2380744585 cites W2087956925 @default.
• W2380744585 cites W2099964125 @default.
• W2380744585 cites W2109518441 @default.
• W2380744585 cites W2111216129 @default.
• W2380744585 cites W2112129392 @default.
• W2380744585 cites W2125677376 @default.
• W2380744585 cites W2128889398 @default.
• W2380744585 cites W2135313371 @default.
• W2380744585 cites W2137119327 @default.
• W2380744585 cites W2137160419 @default.
• W2380744585 cites W2140898921 @default.
• W2380744585 cites W2142741633 @default.
• W2380744585 cites W2158926558 @default.
• W2380744585 cites W2161754779 @default.
• W2380744585 cites W2161935396 @default.
• W2380744585 cites W2162033559 @default.
• W2380744585 cites W2171495193 @default.
• W2380744585 cites W56461633 @default.
• W2380744585 doi "https://doi.org/10.1177/2050640616650062" @default.
• W2380744585 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5349360" @default.
• W2380744585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28344794" @default.
• W2380744585 hasPublicationYear "2017" @default.
• W2380744585 type Work @default.
• W2380744585 sameAs 2380744585 @default.
• W2380744585 citedByCount "18" @default.
• W2380744585 countsByYear W23807445852019 @default.
• W2380744585 countsByYear W23807445852020 @default.
• W2380744585 countsByYear W23807445852021 @default.
• W2380744585 countsByYear W23807445852022 @default.
• W2380744585 countsByYear W23807445852023 @default.
• W2380744585 crossrefType "journal-article" @default.
• W2380744585 hasAuthorship W2380744585A5017285164 @default.
• W2380744585 hasAuthorship W2380744585A5026870084 @default.
• W2380744585 hasAuthorship W2380744585A5027135372 @default.
• W2380744585 hasAuthorship W2380744585A5028721261 @default.
• W2380744585 hasAuthorship W2380744585A5034906246 @default.
• W2380744585 hasAuthorship W2380744585A5045593958 @default.
• W2380744585 hasAuthorship W2380744585A5064699932 @default.
• W2380744585 hasAuthorship W2380744585A5072898235 @default.
• W2380744585 hasAuthorship W2380744585A5073099637 @default.
• W2380744585 hasAuthorship W2380744585A5075930663 @default.
• W2380744585 hasBestOaLocation W23807445851 @default.
• W2380744585 hasConcept C121608353 @default.
• W2380744585 hasConcept C126322002 @default.
• W2380744585 hasConcept C188816634 @default.
• W2380744585 hasConcept C2776956441 @default.
• W2380744585 hasConcept C2778260677 @default.
• W2380744585 hasConcept C2778271842 @default.
• W2380744585 hasConcept C2778292693 @default.
• W2380744585 hasConcept C2778435480 @default.
• W2380744585 hasConcept C2779008522 @default.
• W2380744585 hasConcept C2779134260 @default.
• W2380744585 hasConcept C2779802037 @default.
• W2380744585 hasConcept C526805850 @default.
• W2380744585 hasConcept C71924100 @default.
• W2380744585 hasConcept C90924648 @default.
• W2380744585 hasConceptScore W2380744585C121608353 @default.
• W2380744585 hasConceptScore W2380744585C126322002 @default.
• W2380744585 hasConceptScore W2380744585C188816634 @default.
• W2380744585 hasConceptScore W2380744585C2776956441 @default.
• W2380744585 hasConceptScore W2380744585C2778260677 @default.
• W2380744585 hasConceptScore W2380744585C2778271842 @default.
• W2380744585 hasConceptScore W2380744585C2778292693 @default.
• W2380744585 hasConceptScore W2380744585C2778435480 @default.
• W2380744585 hasConceptScore W2380744585C2779008522 @default.
• W2380744585 hasConceptScore W2380744585C2779134260 @default.

• next